Patrick DeLuca

Title: Patrick DeLuca: Innovator in Pharmaceutical Compositions

Introduction

Patrick DeLuca is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods that enhance drug delivery and stability. With a total of 2 patents, his work has the potential to improve therapeutic outcomes for patients.

Latest Patents

One of Patrick DeLuca's latest patents is titled "Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents." This invention focuses on utilizing tert-butyl alcohol (TBA) co-solvent systems to formulate pharmaceutical agents with low solubility. The method provides a significant improvement in the pharmacotherapy of patients undergoing malignant hyperthermia during surgery by allowing for the instantaneous reconstitution of dantrolene sodium (DS) formulation for intravenous use.

Another important patent is "Polynucleotide composition, method of preparation, and use thereof." This invention describes a lyophilized polynucleotide composition that includes at least one polynucleotide and one cryoprotectant. The composition is characterized by enhanced stability, retaining at least 90% supercoil over a period of at least 10 days at a temperature of about 37°C. The improved process for lyophilization results in a stable, lyophilized polynucleotide composition with better solubility.

Career Highlights

Throughout his career, Patrick DeLuca has worked with prominent companies in the pharmaceutical industry, including Wyeth and US Worldmeds LLC. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Patrick has collaborated with notable professionals in his field, including Shankar Musunuri and Ahmad Malkawi. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical sciences.

Conclusion

Patrick DeLuca is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact patient care. His innovative patents reflect his commitment to advancing drug delivery methods and enhancing the stability of therapeutic agents.